Patent application number | Description | Published |
20130198381 | Optimizing Data Extraction from Distributed Systems into a Unified Event Aggregator Using Time-Outs - Methods and systems of managing automated feed retrieval systems may involve determining an inactivity period with respect to a feed source, and identifying a user time-out threshold corresponding to the feed source. In addition, a re-subscription prompt may be generated if the inactivity period exceeds the user time-out threshold. In one example, a user may be unsubscribed from the feed source if a confirmation response to the re-subscription prompt is not received from the user. Moreover, data retrieval from the feed source can be discontinued if the feed source lacks any remaining subscribers in the automated feed retrieval system. | 08-01-2013 |
20140280613 | EMAIL AS A TRANSPORT MECHANISM FOR ACVITY STREAM POSTING - A method, system and computer program product for utilizing email as a transport mechanism for activity stream posting. The method, program system, and computer product may include receiving an email, with content, at a target email system of a target from a source email system of a source. Content that is to be posted to an activity stream is extracted from the email content. The extracted content is posted to the activity stream. The method, program system, and computer product may further include examining the email at the target to identify whether the email includes content that is to be posted to the activity stream, or the target email system may deliver the email to a designated email address mailbox assigned to emails containing content to be sent to the activity stream. A notification of the email may be provided or the mailbox may be checked for email. | 09-18-2014 |
20140280641 | EMAIL AS A TRANSPORT MECHANISM FOR ACTIVITY STREAM POSTING - A method, system and computer program product for utilizing email as a transport mechanism for activity stream posting. The method, program system, and computer product may include receiving an email, with content, at a target email system of a target from a source email system of a source. Content that is to be posted to an activity stream is extracted from the email content. The extracted content is posted to the activity stream. The method, program system, and computer product may further include examining the email at the target to identify whether the email includes content that is to be posted to the activity stream, or the target email system may deliver the email to a designated email address mailbox assigned to emails containing content to be sent to the activity stream. A notification of the email may be provided or the mailbox may be checked for email. | 09-18-2014 |
Patent application number | Description | Published |
20120328514 | N-ALKOXYAMIDE CONJUGATES AS IMAGING AGENTS - The present disclosure is directed to compounds, diagnostic agents, and related methods. In some cases, methods for treating patients are provided. More specifically, the disclosure provides compounds, diagnostic agents, and kits for detecting and/or imaging and/or monitoring elastin rich tissues. In addition, the disclosure provides methods of detecting and/or imaging and/or monitoring the presence of coronary plaque, carotid plaque, iliac/femoral plaque, aortic plaque, renal artery plaque, plaque of any arterial vessel, aneurism, vasculitis, other diseases of the arterial wall, and/or damage or structural changes in ligaments, uterus, lungs or skin, as indicated by changes in total vessel wall area, internal lumen size, and exterior arterial perimeter. | 12-27-2012 |
20130005944 | CXCR4 Receptor Compounds - The invention relates generally to compounds which are allosteric modulators {e.g., positive and negative allosteric modulators, and allosteric agonists) of the G protein coupled receptor for stromal derived factor 1 (SDF-I), also known as the CXCR4 receptor. The CXCR4 receptor compounds are derived from the intracellular loops and domains of the CXCR4 receptor. The invention also relates to the use of these CXCR4 receptor compounds and pharmaceutical compositions comprising the CXCR4 receptor compounds in the treatment of diseases and conditions associated with CXCR4 modulation such as bone marrow transplantation, chemosensitization, cancer, metastatic disease (e.g., cancer), auto-immune disease (e.g., rheumatoid arthritis), fibrosis disease (e.g., pulmonary), AIDS infection, cardiovascular disease, uveitis, inflammatory diseases, celiac disease HIV infection and stem cell-based regenerative medicine. | 01-03-2013 |
20130149244 | COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS - The present invention generally relates to novel synthetic methods, systems, kits, salts, and precursors useful in medical imaging. In some embodiments, the present invention provides compositions comprising an imaging agent precursor, which may be formed using the synthetic methods described herein. An imaging agent may be converted to an imaging agent using the methods described herein. In some cases, the imaging agent is enriched in | 06-13-2013 |
20130315822 | N-ALKOXYAMIDE CONJUGATES AS IMAGING AGENTS - The present disclosure is directed to compounds, diagnostic agents, and related methods. In some cases, methods for treating patients are provided. More specifically, the disclosure provides compounds, diagnostic agents, and kits for detecting and/or imaging and/or monitoring elastin rich tissues. In addition, the disclosure provides methods of detecting and/or imaging and/or monitoring the presence of coronary plaque, carotid plaque, iliac/femoral plaque, aortic plaque, renal artery plaque, plaque of any arterial vessel, aneurism, vasculitis, other diseases of the arterial wall, and/or damage or structural changes in ligaments, uterus, lungs or skin, as indicated by changes in total vessel wall area, internal lumen size, and exterior arterial perimeter. | 11-28-2013 |
20150078997 | N-ALKOXYAMIDE CONJUGATES AS IMAGING AGENTS - The present disclosure is directed to compounds, diagnostic agents, and related methods. In some cases, methods for treating patients are provided. More specifically, the disclosure provides compounds, diagnostic agents, and kits for detecting and/or imaging and/or monitoring elastin rich tissues. In addition, the disclosure provides methods of detecting and/or imaging and/or monitoring the presence of coronary plaque, carotid plaque, iliac/femoral plaque, aortic plaque, renal artery plaque, plaque of any arterial vessel, aneurism, vasculitis, other diseases of the arterial wall, and/or damage or structural changes in ligaments, uterus, lungs or skin, as indicated by changes in total vessel wall area, internal lumen size, and exterior arterial perimeter. | 03-19-2015 |
20150094465 | N-ALKOXYAMIDE CONJUGATES AS IMAGING AGENTS - The present disclosure is directed to compounds, diagnostic agents, and related methods. In some cases, methods for treating patients are provided. More specifically, the disclosure provides compounds, diagnostic agents, and kits for detecting and/or imaging and/or monitoring elastin rich tissues. In addition, the disclosure provides methods of detecting and/or imaging and/or monitoring the presence of coronary plaque, carotid plaque, iliac/femoral plaque, aortic plaque, renal artery plaque, plaque of any arterial vessel, aneurism, vasculitis, other diseases of the arterial wall, and/or damage or structural changes in ligaments, uterus, lungs or skin, as indicated by changes in total vessel wall area, internal lumen size, and exterior arterial perimeter. | 04-02-2015 |